Profile data is unavailable for this security.
About the company
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
- Revenue in USD (TTM)8.34m
- Net income in USD-10.92m
- Incorporated2008
- Employees31.00
- LocationReShape Lifesciences Inc1001 CALLE AMANECERSAN CLEMENTE 92673United StatesUSA
- Phone+1 (949) 429-6680
- Fax+1 (302) 636-5454
- Websitehttps://www.reshapelifesciences.com/obalon/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avinger Inc | 7.62m | -16.13m | 3.86m | 68.00 | -- | -- | -- | 0.5069 | -18.16 | -18.16 | 7.49 | -2.56 | 0.4084 | 1.20 | 6.38 | 112,102.90 | -102.83 | -70.93 | -- | -131.57 | 22.43 | 30.87 | -251.78 | -208.91 | 0.4764 | -10.02 | 1.38 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
| Catheter Precision Inc | 439.00k | -6.85m | 3.98m | 14.00 | -- | 0.2149 | -- | 9.07 | -1.03 | -1.03 | 0.0659 | 2.45 | 0.0115 | 0.3759 | 5.74 | 31,357.14 | -17.89 | -- | -19.64 | -- | 94.31 | -- | -1,559.68 | -- | 0.8047 | -- | 0.004 | -- | 3,057.14 | -- | -165.67 | -- | -- | -- |
| Heart Test Laboratories Inc | 18.60k | -6.39m | 4.20m | 12.00 | -- | 47.23 | -- | 225.94 | -0.4912 | -0.4912 | 0.0009 | 0.1357 | 0.0026 | 0.009 | 2.53 | 1,550.00 | -89.51 | -- | -120.71 | -- | 67.31 | -- | -34,362.42 | -- | 4.70 | -16.41 | 0.0547 | -- | -64.16 | -- | -31.61 | -- | -- | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 4.77m | 15.00 | -- | -- | -- | 2.10 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
| ReShape Lifesciences Inc | 8.34m | -10.92m | 4.87m | 31.00 | -- | 1.08 | -- | 0.5848 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 4.94m | 9.00 | -- | -- | -- | 3.07 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| ADM Tronics Unlimited Inc | 2.85m | -716.86k | 4.97m | 7.00 | -- | 4.51 | -- | 1.75 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
| Hawkeye Systems Inc | 0.00 | -804.18k | 5.08m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
| Nuwellis Inc | 8.90m | -19.93m | 5.12m | 59.00 | -- | 2.18 | -- | 0.5759 | -8.30 | -8.30 | 2.73 | 0.1304 | 0.7076 | 1.55 | 7.04 | 150,762.70 | -143.62 | -98.07 | -216.07 | -122.48 | 57.41 | 55.22 | -202.97 | -230.51 | 0.7092 | -4.75 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
| Vapotherm Inc | 70.07m | -54.94m | 5.23m | 182.00 | -- | -- | -- | 0.0746 | -8.62 | -8.62 | 11.00 | -11.02 | 0.8122 | 1.46 | 7.53 | 385,011.00 | -63.68 | -49.73 | -587.27 | -62.54 | 45.28 | 43.56 | -78.40 | -78.99 | 0.1259 | -1.27 | 2.59 | -- | 2.80 | 10.14 | 48.62 | -- | -10.38 | -- |
| Arch Therapeutics Inc | 130.55k | -8.43m | 5.29m | 8.00 | -- | -- | -- | 40.51 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| BIOLASE Inc | 49.16m | -37.62m | 5.61m | 157.00 | -- | -- | -- | 0.1142 | -37.97 | -37.97 | 38.54 | 0.5726 | 1.34 | 2.38 | 8.68 | 313,146.50 | -56.30 | -49.28 | -115.21 | -85.80 | 34.02 | 35.27 | -41.97 | -50.72 | 0.683 | -6.61 | 0.8778 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| SINTX Technologies Inc | 2.78m | -8.88m | 5.69m | 43.00 | -- | 0.2388 | -- | 2.05 | -389.94 | -389.94 | 74.21 | 38.86 | 0.138 | 1.62 | 5.84 | 64,534.88 | -44.03 | -45.71 | -57.11 | -57.36 | 67.96 | 58.47 | -318.99 | -681.80 | 1.67 | -- | 0.0229 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| Encision Inc | 6.87m | -448.00k | 5.88m | 31.00 | -- | 2.68 | -- | 0.8568 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 6.06m | 31.00 | 2.28 | -- | 1.64 | 0.3295 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Guided Therapeutics Inc | 82.00k | -3.23m | 6.07m | 4.00 | -- | -- | -- | 74.02 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
Data as of May 28 2024. Currency figures normalised to ReShape Lifesciences Inc's reporting currency: US Dollar USD
1.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 49.87k | 0.21% |
| Tower Research Capital LLCas of 31 Mar 2024 | 49.57k | 0.21% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 34.06k | 0.15% |
| Millennium Management LLCas of 31 Mar 2024 | 29.79k | 0.13% |
| Gesalcal� SA SGIICas of 31 Dec 2023 | 26.01k | 0.11% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 23.04k | 0.10% |
| Jane Street Capital LLCas of 31 Mar 2024 | 22.93k | 0.10% |
| Geode Capital Management LLCas of 31 Mar 2024 | 18.35k | 0.08% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 13.02k | 0.06% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 12.82k | 0.06% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
